The Federal Reserve finally blinked. On Wednesday, as almost everyone on Wall Street had already predicted, the U.S. central bank trimmed the federal funds rate by 0.25%, lowering its target range to 4.00%–4.25%. The move came against a backdrop of souring economic data, nervous investors, and relentless political pressure from Donald Trump, who has made Fed-bashing as routine as his morning tweets.The Federal Reserve finally blinked. On Wednesday, as almost everyone on Wall Street had already predicted, the U.S. central bank trimmed the federal funds rate by 0.25%, lowering its target range to 4.00%–4.25%. The move came against a backdrop of souring economic data, nervous investors, and relentless political pressure from Donald Trump, who has made Fed-bashing as routine as his morning tweets.

The Fed Cuts Rates by 25bps, Bitcoin Steady For Now

2025/09/18 03:07
The Federal Reserve finally blinked. On Wednesday, as almost everyone on Wall Street had already predicted, the U.S. central bank trimmed the federal funds rate by 0.25%, lowering its target range to 4.00%–4.25%. The move came against a backdrop of souring economic data, nervous investors, and relentless political pressure from Donald Trump, who has made Fed-bashing as routine as his morning tweets.

A Labor Department revision revealed 911,000 fewer jobs were created over the past year than previously reported—basically a statistical gut punch to the “strong labor market” narrative. Combine that with sluggish growth signals and a creeping sense of slowdown, and the Fed was boxed in. “Uncertainty about the economic outlook remains elevated,” the central bank conceded in its statement—bureaucratic-speak for we’re worried.

Inflation vs. Jobs: The Balancing Act

Cutting rates with inflation at 2.9% (still above the Fed’s sacred 2% target) is no small gamble. But the central bank’s dual mandate—stable prices and maximum employment—forced its hand. Interestingly, newly installed governor Stephen Miran, Trump’s pick, dissented, calling for a 0.50% cut. His view? Go bigger, faster. Other hawkish members like Michelle Bowman and Christopher Waller, who previously opposed cuts, begrudgingly agreed that a quarter-point was “enough for now.”

Bitcoin, Ethereum, and the “Priced In” Trade

Crypto markets barely twitched. Bitcoin traded just north of $116,000, a rounding-error move of 0.2% over the previous hours, according to CoinGecko. Ethereum sat flat around $4,501. That’s because markets had already priced in this cut weeks ago—the CME’s FedWatch tool put the odds of a reduction at 96% heading into the meeting. Traders were more interested in the tea leaves of Powell’s press conference and the Fed’s updated economic projections, which now signal two more cuts possible before year’s end.

The Federal Reserve finally blinked. On Wednesday, as almost everyone on Wall Street had already predicted, the U.S. central bank trimmed the federal funds rate by 0.25%, lowering its target range to 4.00%–4.25%. The move came against a backdrop of souring economic data, nervous investors, and relentless political pressure from Donald Trump, who has made Fed-bashing as routine as his morning tweets.

Bitcoin briefly topped $117,000 before pulling back, Source: BNC

Politics, Power Plays, and Gold at Record Highs

The rate cut didn’t happen in a vacuum. Trump has been at war with Powell’s Fed for months, accusing it of dragging its feet and threatening to replace governors with his own dovish loyalists. He just installed Miran to finish out a short term, and even tried (unsuccessfully) to oust Governor Lisa Cook—who, ironically, isn’t considered especially hawkish. A federal appeals court blocked that move, underscoring how messy the White House-Fed relationship has become.

Polymarket is now predicting further rate cuts to come this year.

The Federal Reserve finally blinked. On Wednesday, as almost everyone on Wall Street had already predicted, the U.S. central bank trimmed the federal funds rate by 0.25%, lowering its target range to 4.00%–4.25%. The move came against a backdrop of souring economic data, nervous investors, and relentless political pressure from Donald Trump, who has made Fed-bashing as routine as his morning tweets.

Two more rates cuts are predicted this year, Source: Polymarket

Meanwhile, safe-haven buyers are voting with their wallets. Gold surged to a record $3,730 this week, up more than 10% in a month as investors hedge against both inflation and Trump-era chaos. If Bitcoin is supposed to be “digital gold,” it’s not showing it—at least not yet.

This cut was expected, priced in, and, frankly, underwhelming in immediate market terms. The real drama lies ahead: whether Powell signals further easing, whether Trump keeps meddling, and whether investors decide Bitcoin deserves to trade more like gold in this uncertain environment.

 

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Novo Nordisk cuts cash prices for Wegovy, Ozempic

Novo Nordisk cuts cash prices for Wegovy, Ozempic

The post Novo Nordisk cuts cash prices for Wegovy, Ozempic appeared on BitcoinEthereumNews.com. Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024. Hollie Adams | Reuters Novo Nordisk on Monday said it has cut the direct-to-consumer prices of its blockbuster weight loss drug Wegovy and diabetes counterpart Ozempic, adding to efforts by the company and the Trump administration to make the treatments more accessible.  The Danish drugmaker is lowering the price of the drugs for existing cash-paying patients to $349 per month from $499 per month. But Novo Nordisk said the cash-pay cost of the highest dose of Ozempic will remain $499 per month.  Also on Monday, Novo Nordisk launched a temporary introductory offer, which will allow new cash-paying patients to access the two lowest doses of Wegovy and Ozempic for $199 per month for the first two months of treatment. After that period, people move to the new standard monthly direct-to-consumer price. The company’s introductory offer ends on March 31.  The announcements come days after President Donald Trump struck deals with Novo Nordisk and chief rival Eli Lilly to make their popular GLP-1 drugs easier for Americans to access and afford. Those agreements will involve cutting the prices the government pays for the drugs, introducing Medicare coverage of obesity drugs for the first time for certain patients and offering discounted medicines on the government’s new direct-to-consumer website launching in January called TrumpRx.  “Our new savings offers provide immediate impact, bringing forward greater cost savings for those who are currently without coverage or choose to self-pay,” said Dave Moore, Novo Nordisk’s head of U.S. operations, said in a release. “It is part of a larger strategy to expand access that includes building relationships with telehealth providers and major retailers, expanding coverage, and working with the Administration to lower costs for people living with chronic diseases like…
Share
BitcoinEthereumNews2025/11/17 21:30